Johnson & Johnson MedTech Neurovascular Worldwide President Mark Dickinson is leaving J&J after a 26-year career.

Class II recalls — a grade below the most serious Class I recalls — reference a situation in which the use of or exposure to ...

Helius Medical Technologies (Nasdaq:HSDT) announced today that it established Revelation Neuro, a brain-computer interface ...

Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic ...

Lifeward announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk ...

Johnson & Johnson MedTech announced today that the FDA cleared its Monarch Quest technology for robotic-assisted bronchoscopy ...

Olympus announced that it launched its first AI-powered clinical decision tool in collaboration with software company Ziosoft ...

Among major medtech stocks, Intuitive Surgical, Boston Scientific and Stryker have had an especially rough week.

Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding ...

Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...

Signum Surgical, maker of the BioHealx implant system, announced today that it appointed Carol Burns as its new CEO.

Vivani Medical (Nasdaq:VANI) today announced steps enabling it to focus solely on its GLP-1-delivering implant technologies.